Ocular Pharmacokinetics of a Topical Ophthalmic Nanomicellar Solution of Cyclosporine (Cequa®) for Dry Eye Disease
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Link
http://link.springer.com/article/10.1007/s11095-018-2556-5/fulltext.html
Reference93 articles.
1. Javadi MA, Feizi S. Dry eye syndrome. J Ophthalmic Vis Res. 2011;6(3):192–8.
2. Gayton JL. Etiology, prevalence, and treatment of dry eye disease. Clin Ophthalmol. 2009;3:405–12.
3. Hawkes N. US's $2bn annual spend on dry eye disease "brings tears to your eyes," say critics. BMJ. 2018;360:k492.
4. Yu J, Asche CV, Fairchild CJ. The economic burden of dry eye disease in the United States: a decision tree analysis. Cornea. 2011;30(4):379–87.
5. Tsubota K. Tear dynamics and dry eye. Prog Retin Eye Res. 1998;17(4):565–96.
Cited by 102 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nanomedicine in glaucoma treatment; Current challenges and future perspectives;Materials Today Bio;2024-10
2. Block copolymer micelles as ocular drug delivery systems;Drug Discovery Today;2024-08
3. Insights into ocular therapeutics: A comprehensive review of anatomy, barriers, diseases and nanoscale formulations for targeted drug delivery;Journal of Drug Delivery Science and Technology;2024-08
4. The evolution of cyclosporine treatments for treatment of ocular surface diseases;Current Opinion in Allergy & Clinical Immunology;2024-07-24
5. Pharmaceutical Emulsions: A Viable Approach for Ocular Drug Delivery;Journal of Ocular Pharmacology and Therapeutics;2024-06-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3